Single-cell transcriptomic reconstruction reveals cell cycle and multi-lineage differentiation defects in Bcl11a-deficient hematopoietic stem cells

88Citations
Citations of this article
176Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Hematopoietic stem cells (HSCs) are a rare cell type with the ability of long-term self-renewal and multipotency to reconstitute all blood lineages. HSCs are typically purified from the bone marrow using cell surface markers. Recent studies have identified significant cellular heterogeneities in the HSC compartment with subsets of HSCs displaying lineage bias. We previously discovered that the transcription factor Bcl11a has critical functions in the lymphoid development of the HSC compartment. Results: In this report, we employ single-cell transcriptomic analysis to dissect the molecular heterogeneities in HSCs. We profile the transcriptomes of 180 highly purified HSCs (Bcl11a +/+ and Bcl11a -/-). Detailed analysis of the RNA-seq data identifies cell cycle activity as the major source of transcriptomic variation in the HSC compartment, which allows reconstruction of HSC cell cycle progression in silico. Single-cell RNA-seq profiling of Bcl11a -/- HSCs reveals abnormal proliferative phenotypes. Analysis of lineage gene expression suggests that the Bcl11a -/- HSCs are constituted of two distinct myeloerythroid-restricted subpopulations. Remarkably, similar myeloid-restricted cells could also be detected in the wild-type HSC compartment, suggesting selective elimination of lymphoid-competent HSCs after Bcl11a deletion. These defects are experimentally validated in serial transplantation experiments where Bcl11a -/- HSCs are myeloerythroid-restricted and defective in self-renewal. Conclusions: Our study demonstrates the power of single-cell transcriptomics in dissecting cellular process and lineage heterogeneities in stem cell compartments, and further reveals the molecular and cellular defects in the Bcl11a-deficient HSC compartment.

Figures

  • Fig. 1 Single-cell transcriptome profiling of mouse HSCs by microfluidic system. a Gating strategy for HSC purification. Bcl11a+/+ and Bcl11a−/− HSCs were isolated by sorting markers LSK CD150+48− and sBcl11a+/+ HSCs by markers LSK CD150+48−34−135−. Lineage markers used for enrichment included B220, CD19, CD3, CD4, CD8, TCRγδ, TCRβ, NK1.1, CD11b, Gr-1, Ter119. FSC: Forward scatter, SSC: Side scatter. b Single-cell capturing efficiency by the C1 AutoPrep microfluidic system and representative microscopic images of individual capture sites. A representative high-quality single HSC at an individual capture site is indicated by the red arrow. Representative pictures of poor quality cells, an empty capture site and a multiplet capture site are framed in colors as indicated in the key. c Principal component analysis of the transcriptome of all 181 HSCs passed initial computational quality control. One significant outlier from the Bcl11a+/+ dataset was identified (marked by red arrow). It was removed from subsequent analysis. d Boxplot comparing the number of genes detected (normalized count >1) in the sBcl11a+/+ and Bcl11a+/+ datasets. The two datasets were comparable, despite low sequencing depth of the sBcl11a+/+ dataset
  • Fig. 2 (See legend on next page.)
  • Fig. 3 (See legend on next page.)
  • Fig. 4 (See legend on next page.)
  • Fig. 5 Bcl11a-deficient HSCs show self-renewal defects. a Gene set enrichment analysis showing significant depletion of the self-renewal gene signature in Bcl11a−/− HSCs (p < 0.001). The normalized enrichment score (NES) of 1.64 indicates significantly higher self-renewal gene expression in the Bcl11a+/+ HSCs compared with Bcl11a−/− HSCs. b Percentage of donor cells in total nucleated peripheral blood (PBL) cells along with time after transfer. We injected 2000 Bcl11a+/− or Bcl11a−/− LSKs (CD45.1−) with 1.0 × 106 bone marrow (BM) cells (CD45.1+) into sublethally irradiated recipient mice (CD45.1+). c Comparison of the number of donor LSK cells and HSCs in secondary recipient mice 18 weeks post-secondary transfer; *p < 0.05, **p < 0.01. d FACS dot plot of donor Bcl11a+/− and Bcl11a−/− HSCs (LSK CD150+48− and LSK CD34−135(Flt3)−) in secondary recipient mice. BM cells were analyzed 18 weeks post-secondary transfer. Bcl11a+/−, CreERT2; Bcl11a+/flox (treated with tamoxifen); Bcl11a−/−, CreERT2; Bcl11aflox/flox (treated with tamoxifen). In panels (b) and (c), at least three mice were used for each time point or each cell type in independent experiments. The error bar represented mean ± 1 standard deviation
  • Fig. 6 (See legend on next page.)

References Powered by Scopus

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

36149Citations
17901Readers
Get full text

This article is free to access.

This article is free to access.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tsang, J. C. H., Yu, Y., Burke, S., Buettner, F., Wang, C., Kolodziejczyk, A. A., … Liu, P. (2015). Single-cell transcriptomic reconstruction reveals cell cycle and multi-lineage differentiation defects in Bcl11a-deficient hematopoietic stem cells. Genome Biology, 16(1). https://doi.org/10.1186/s13059-015-0739-5

Readers over time

‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘25010203040

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 74

58%

Researcher 40

31%

Professor / Associate Prof. 10

8%

Lecturer / Post doc 3

2%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 55

44%

Biochemistry, Genetics and Molecular Bi... 45

36%

Medicine and Dentistry 16

13%

Computer Science 9

7%

Article Metrics

Tooltip
Mentions
References: 1

Save time finding and organizing research with Mendeley

Sign up for free
0